PCB126 (5 μmol/kg mouse, gavage, in weeks 10, 11, and 12) |
Green tea extract (1%GTE-supplemented diet, oral, 12 weeks) |
C57BL/6 mice |
Liver injury. Reduce the expression of key markers of inflammation (MCP-1 and CCL3) |
Upregulate a battery of antioxidant enzymes; upregulate genes transcriptionally controlled by AhR and Nrf2 proteins |
33
|
PCB126 (1.5 mg/kg, gavage, twice a week for two weeks) |
Inulin (250 mg/kg/day fiber, given drinking water containing inulin, throughout the PCB126 |
male C57BL/6 J mice |
Liver inflammation and fibrosis. Inulin treatment decreases the hepatic mRNA levels of TNFα, Ccl2, Ccl3, CoL1a1, and Sirius red staining |
Affect the structure of gut microbiome. Inhibit PCB126-induced reduction of intestinal ZO-1 expression and reduce the release of inflammatory cytokines |
111
|
PCB126 (1 μmol/kg, oral gavage, at weeks 2 and 4) |
A high cholesterol diet with 8% inulin, 12 weeks |
male Ldlr−/− mice |
Atherosclerosis. Inulin decreases aortic root lesion area in Ldlr−/− mice |
Production of protective metabolites, decrease in atherogenic lipoproteins and cholesterol |
34
|
POPs (diet containing a mixture of POPs, including PCB, PBDE, dioxin, and DDT weeks 0 to 10) |
Cranberry extract (200 mg/kg, from week 10 to week 16) |
male C57BL/6J mice |
Harmful effects of the weight loss process. Cranberry extract treatment leads to lower fasting glycemia and improved glucose tolerance |
Improve glucose homeostasis, target the gut microbiota, and increase the relative abundance of Parvibacter
|
125
|
POPs (PCBs and organochlorine pesticides) |
Vitamin C (1000 mg/day Vitamin C, oral, 2 months) |
15 healthy California women |
Blood concentrations of POPs |
Reduce body burdens of POPs |
113
|